MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. financial statements

MapLight Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 161.15M10-K
Cash and equivalentsUSD 46.73M10-Q
Total debtUSD 5.8MEODHD

MapLight Therapeutics, Inc. financials on 6ix · MapLight Therapeutics, Inc. on 6ix